消费者保健市场规模、份额、成长分析、按产品、分销管道、按地区 - 产业预测，2024-2031 年

Consumer Healthcare Market Size, Share, Growth Analysis, By Product (OTC Pharmaceuticals, Personal Care Products), By Distribution Channel (Online, Offline), By Region - Industry Forecast 2024-2031

出版日期: 2024年09月26日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球消费者医疗保健市场规模为2,810亿美元，从2023年的3023.6亿美元成长到2031年的5,432.7亿美元，预计在预测期内（2024-2031年）将成长。 %。

消费者保健包括健康、口腔护理、营养和皮肤健康等广泛的产品。其中许多产品是非处方（OTC）产品，例如维生素和矿物质补充品，无需处方笺即可直接出售给消费者。常见的非处方药产品包括牙膏、漱口水、眼药水、除疣剂、抗生素霜和药膏以及去屑洗髮精。全球消费保健市场的关键驱动因素之一是老年人口不断增加，他们更容易受到健康状况的影响，增加了对非处方药产品的需求。然而，市场面临挑战，因为含有不准确或低品质活性药物成分 (API) 的仿冒品阻碍了市场成长。世界各国政府已采取倡议遏制这些仿冒品的生产和销售，从而促进可靠且值得信赖的消费者保健品的成长。此外，不断上涨的医疗保健成本正促使消费者选择更实惠的处方药替代品，为消费者医疗保健市场提供了巨大的成长机会。从传统零售向网路购物平台的日益转变也为市场参与企业提供了广阔的前景。 PharmEasy、vitacost.com、healthkart.com、MedlinePlus 和 vivavitamins.com 等网站提供各种维生素产品、蛋白质饮料和补充品，让消费者可以轻鬆地在线上取得保健产品。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Teva Pharmaceutical Industries Limited（Israel）
Abbott Laboratories（US）
GlaxoSmithKline plc（UK）
Sanofi SA（France）
BASF SE（Germany）
Boehringer Ingelheim International GmbH（Germany）
Amway Corp.（US）
Pfizer Inc.（US）
Bayer AG（Germany）
Johnson & Johnson（US）
Reckitt Benckiser Group plc（UK）
Nestle Health Science（Switzerland）
Procter & Gamble Co.（US）
Unilever plc（UK）
Novartis AG（Switzerland）
Herbalife Nutrition Ltd.（US）
DSM Nutritional Products（Netherlands）
Himalaya Global Holdings Ltd.（India）
Perrigo Company plc（Ireland）
Merck KGaA（Germany）
Dabur India Ltd.（India）
Sun Pharmaceutical Industries Ltd.（India）

简介目录

Product Code: SQMIG35D2021

Global Consumer Healthcare Market size was valued at USD 281 billion in 2022 and is poised to grow from USD 302.36 billion in 2023 to USD 543.27 billion by 2031, growing at a CAGR of 7.60% during the forecast period (2024-2031).

Consumer healthcare encompasses a wide range of products, including those for wellness, oral care, nutrition, and skin health. Many of these items fall under over-the-counter (OTC) medications, such as vitamins and mineral supplements, which are sold directly to consumers without the need for a prescription. Common OTC products include various types of toothpaste, mouthwash, eye drops, wart removers, first aid creams and ointments with antibiotics, and anti-dandruff shampoos. One key driver of the global consumer healthcare market is the growing elderly population, which is more susceptible to health conditions, thus increasing the demand for OTC products. However, the market faces challenges due to the presence of counterfeit products containing inaccurate or low-quality active pharmaceutical ingredients (API), which hamper market growth. Governments worldwide are implementing initiatives to curb the production and sale of these counterfeit products, thereby fostering the growth of reliable and trusted consumer healthcare items. Additionally, rising healthcare costs are prompting consumers to opt for more affordable alternatives to prescription medications, offering a significant growth opportunity for the consumer healthcare market. The increasing shift from traditional retail to online shopping platforms also presents promising prospects for market participants. Websites like PharmEasy, vitacost.com, healthkart.com, MedlinePlus, and vivavitamins.com offer a wide array of vitamin products, protein drinks, and supplements, making it easier for consumers to access healthcare products online.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Consumer Healthcare market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Consumer Healthcare Market Segmental Analysis

Global Consumer Healthcare Market is segmented by Product, Distribution Channel, and region. Based on Product, the market is segmented into OTC Pharmaceuticals, Personal Care Products, and Dietary Supplements. Based on Distribution Channel, the market is segmented into Online, and Offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Consumer Healthcare Market

Today, people are increasingly prioritizing their health and are actively seeking innovative ways to maintain their well-being. As a result, many consumers are turning to self-medication as their first line of defense against common health issues, rather than seeking alternative treatments. This shift has significantly boosted the demand for preventative healthcare products, particularly over-the-counter (OTC) medications, which have seen substantial growth in the global consumer healthcare market. Self-medication offers the convenience of easy access to OTC drugs at a lower cost, making it a more affordable and quicker option than expensive and time-consuming clinical visits. For instance, individuals experiencing minor health issues like nasal congestion, cold, or cough can easily purchase inhalers, tablets, or balms from a store without the need for a prescription. Moreover, these self-medication products are widely available, even in rural areas, ensuring that a broader population has access to essential healthcare solutions.

Restraints in the Global Consumer Healthcare Market

The misuse, overuse, and abuse of readily available over-the-counter (OTC) drugs pose significant challenges to the growth of the global consumer healthcare market. It is not uncommon for consumers worldwide to misuse these medications, using them in ways that differ from their intended purposes. For instance, the Consumer Healthcare Products Association (CHPA) has noted a concerning trend where a small but increasing number of individuals abuse loperamide to self-manage opioid withdrawal or to achieve a euphoric high. In addition to this, reports have surfaced of individuals using OTC drugs recreationally, further highlighting the risks of improper usage. Such misuse not only endangers consumer health but also presents legal and financial risks for manufacturers, who may be held accountable for product harm in various cases, even if the drugs are not used as intended. These issues, if left unchecked, could negatively impact the consumer healthcare market's reputation and growth prospects.

Market Trends of the Global Consumer Healthcare Market

People worldwide are becoming increasingly health-conscious, recognizing the impact of personal lifestyle choices on both their own health and that of others. This growing awareness is driving a shift in how individuals approach healthcare, encouraging them to take ownership of their well-being and explore ways to improve and maintain their health independently. This trend towards self-health advocacy is expected to fuel growth in the consumer healthcare market across multiple sectors. Additionally, self-care practices can help reduce the strain on healthcare systems and government resources by empowering individuals to manage their health proactively. As more people adopt self-care routines, the demand for consumer healthcare products, particularly over-the-counter solutions and preventative care, is likely to rise, further contributing to market expansion.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Consumer Healthcare Market by Product

Market Overview
OTC Pharmaceuticals
Personal Care Products
Dietary Supplements

Consumer Healthcare Market by Distribution Channel

Market Overview
Online
Offline
- Supermarkets and Hypermarkets
- Pharmacies
- Others

Consumer Healthcare Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Teva Pharmaceutical Industries Limited (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim International GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amway Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reckitt Benckiser Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nestle Health Science (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Procter & Gamble Co. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Unilever plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Herbalife Nutrition Ltd. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DSM Nutritional Products (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Himalaya Global Holdings Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dabur India Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments